Boyds, a consultancy business supporting the development of pharmaceutical and biotech products and devices, has welcomed Céline Courtay-Cahen to its growing Regulatory Affairs team.
Courtay-Cahen, who has joined the firm as a Regulatory Affairs Consultant, is an experienced researcher with a background in molecular biology and cancer genomics, having worked for many years on chromosomal rearrangements and mutations occurring during cancer progression.
Working with the Regulatory Affairs team out of the Cambridge, UK office, Courtay-Cahen will be managing projects including orphan drug designation, clinical trial applications and marketing authorisation applications.
She joins Boyds from Envigo Pharma Consulting where she was a Regulatory Affairs Consultant and worked on gene therapy projects, orphan drug applications, paediatric products, modules 3 and 4 for MAA and pharmacovigilance.
Prior to that, she held various research positions including roles at the Institute of Structural Biology in Grenoble; the Faculty of Medicine at the Free University of Brussels; the Department of Pathology at the University of Cambridge and the Animal Health Trust in Newmarket.